The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease.
By A. Cuthbert, S. Fisher, M. Mirza, K. King, J. Hampe, P. Croucher, S. Mascheretti, J. Sanderson, A. Forbes, J. Mansfield and 3 more. Gastroenterology, 2002
709 citations recorded by the source corpus.
Subfields: Genetics, Immunology, Neurology
View Paper: https://www.semanticscholar.org/paper/7ea75921cf44f0c8dece4ec145640a7b7dcd1a72
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Genetics
In Immunology
Citations in the corpus
- Inflammatory bowel disease: Epidemiology, pathogenesis, and therapeutic opportunities (2006, background): “20-fold increased risk of developing CD, particularly ileal disease.(35) Heterozygous individuals are also at greater risk, especially as the number of mutations increases.”